When considering any stock for your portfolio, don't be swayed by just the positives. Examine its pros and cons, and decide whether its possible upside outweighs its risks...MannKind, with a market capitalization of about $376 million, is a biotechnology company known for developing therapies...
FULL ARTICLE AT The Motley Fool